Jed Latkin | Chief Executive Officer, Chief Financial Officer, Chief Operating Officer |
Mike Rosol | Chief Medical Officer |
Erika Eves | Director of Finance and Administration |
Michael Okunewitch | Maxim Group |
Joe Pellicane | Private Investor |
Mike Rigali | Private Investor |
Greeting and welcome to the Navidea Biopharmaceuticals quarter one 2020 earnings conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions].
As a reminder, this conference is being recorded.